Listed

Aardvark Therapeutics, Inc.

AARDNasdaqCIK 1774857HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$15.1m, Q2 FY2026
Net income−$14.4m, Q2 FY2026
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30period not labelled2024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reported0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-13, accession 0000950170-25-108116. Derived: 6-month figure less the 3-month figure.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-13, accession 0001193125-25-280260. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-119770. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-344987. Derived: 6-month figure less the 3-month figure.Report this figure
Research and development$m1.2Research and development, period not labelled, three months to 2024-03-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure4.0Research and development, period not labelled, three months to 2024-06-30$4.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0000950170-25-108116.Report this figure4.1Research and development, period not labelled, three months to 2024-09-30$4.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure8.1Research and development, period not labelled, three months to 2024-12-31$8.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001193125-26-119770. Derived: 12-month figure less the 9-month figure.Report this figure7.8Research and development, Q1 FY2025, three months to 2025-03-31$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure13.1Research and development, Q2 FY2025, three months to 2025-06-30$13.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure13.7Research and development, Q3 FY2025, three months to 2025-09-30$13.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure14.3Research and development, Q4 FY2025, three months to 2025-12-31$14.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001193125-26-119770. Derived: 12-month figure less the 9-month figure.Report this figure16.6Research and development, Q1 FY2026, three months to 2026-03-31$16.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure10.5Research and development, Q2 FY2026, three months to 2026-06-30$10.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure
Operating income$m(2.2)Operating income, period not labelled, three months to 2024-03-31−$2.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure(6.1)Operating income, period not labelled, three months to 2024-06-30−$6.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0000950170-25-108116.Report this figure(5.1)Operating income, period not labelled, three months to 2024-09-30−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure(9.5)Operating income, period not labelled, three months to 2024-12-31−$9.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-119770. Derived: 12-month figure less the 9-month figure.Report this figure(10.5)Operating income, Q1 FY2025, three months to 2025-03-31−$10.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure(15.8)Operating income, Q2 FY2025, three months to 2025-06-30−$15.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure(17.7)Operating income, Q3 FY2025, three months to 2025-09-30−$17.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure(18.7)Operating income, Q4 FY2025, three months to 2025-12-31−$18.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-119770. Derived: 12-month figure less the 9-month figure.Report this figure(22.5)Operating income, Q1 FY2026, three months to 2026-03-31−$22.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure(15.1)Operating income, Q2 FY2026, three months to 2026-06-30−$15.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure
Net income$m(2.2)Net income, period not labelled, three months to 2024-03-31−$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure(5.4)Net income, period not labelled, three months to 2024-06-30−$5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-13, accession 0000950170-25-108116.Report this figure(4.2)Net income, period not labelled, three months to 2024-09-30−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure(8.8)Net income, period not labelled, three months to 2024-12-31−$8.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-119770. Derived: 12-month figure less the 9-month figure.Report this figure(9.3)Net income, Q1 FY2025, three months to 2025-03-31−$9.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure(14.4)Net income, Q2 FY2025, three months to 2025-06-30−$14.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure(16.3)Net income, Q3 FY2025, three months to 2025-09-30−$16.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure(17.6)Net income, Q4 FY2025, three months to 2025-12-31−$17.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-119770. Derived: 12-month figure less the 9-month figure.Report this figure(21.6)Net income, Q1 FY2026, three months to 2026-03-31−$21.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure(14.4)Net income, Q2 FY2026, three months to 2026-06-30−$14.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure
Diluted EPS$ per share(0.55)Diluted EPS, period not labelled, three months to 2024-03-31−$0.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure(1.37)Diluted EPS, period not labelled, three months to 2024-06-30−$1.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0000950170-25-108116.Report this figure(1.05)Diluted EPS, period not labelled, three months to 2024-09-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figurenot reported(0.71)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure(0.66)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure(0.75)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figurenot reported(0.99)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure(0.66)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure
Basic EPS$ per share(0.55)Basic EPS, period not labelled, three months to 2024-03-31−$0.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure(1.37)Basic EPS, period not labelled, three months to 2024-06-30−$1.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0000950170-25-108116.Report this figure(1.05)Basic EPS, period not labelled, three months to 2024-09-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figurenot reported(0.71)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure(0.66)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure(0.75)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figurenot reported(0.99)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.99 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure(0.66)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure

Balance sheet

Cash and equivalents$73.8m, Q2 FY2026
Shareholders' equity$74.8m, Q2 FY2026
Line itemUnitperiod not labelled2023-12-31period not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30period not labelled2024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reportednot reportednot reportednot reported61.6Cash and equivalents, period not labelled, at 2024-12-31$61.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-23, accession 0001193125-26-119770.Report this figure26.5Cash and equivalents, Q1 FY2025, at 2025-03-31$26.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure26.0Cash and equivalents, Q2 FY2025, at 2025-06-30$26.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0000950170-25-108116.Report this figure39.3Cash and equivalents, Q3 FY2025, at 2025-09-30$39.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure47.1Cash and equivalents, FY2025, at 2025-12-31$47.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure62.4Cash and equivalents, Q1 FY2026, at 2026-03-31$62.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure73.8Cash and equivalents, Q2 FY2026, at 2026-06-30$73.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure
Current assets$mnot reportednot reportednot reportednot reported74.1Current assets, period not labelled, at 2024-12-31$74.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-23, accession 0001193125-26-119770.Report this figure155Current assets, Q1 FY2025, at 2025-03-31$154.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure145Current assets, Q2 FY2025, at 2025-06-30$144.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0000950170-25-108116.Report this figure129Current assets, Q3 FY2025, at 2025-09-30$129.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure112Current assets, FY2025, at 2025-12-31$111.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure93.6Current assets, Q1 FY2026, at 2026-03-31$93.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure80.7Current assets, Q2 FY2026, at 2026-06-30$80.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure
Total assets$mnot reportednot reportednot reportednot reported77.5Total assets, period not labelled, at 2024-12-31$77.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-23, accession 0001193125-26-119770.Report this figure157Total assets, Q1 FY2025, at 2025-03-31$157.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure147Total assets, Q2 FY2025, at 2025-06-30$147.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0000950170-25-108116.Report this figure133Total assets, Q3 FY2025, at 2025-09-30$133.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure117Total assets, FY2025, at 2025-12-31$117.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure98.6Total assets, Q1 FY2026, at 2026-03-31$98.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure81.5Total assets, Q2 FY2026, at 2026-06-30$81.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure
Current liabilities$mnot reportednot reportednot reportednot reported4.9Current liabilities, period not labelled, at 2024-12-31$4.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-23, accession 0001193125-26-119770.Report this figure6.0Current liabilities, Q1 FY2025, at 2025-03-31$6.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure10.3Current liabilities, Q2 FY2025, at 2025-06-30$10.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0000950170-25-108116.Report this figure10.7Current liabilities, Q3 FY2025, at 2025-09-30$10.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure10.5Current liabilities, FY2025, at 2025-12-31$10.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure11.6Current liabilities, Q1 FY2026, at 2026-03-31$11.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure6.4Current liabilities, Q2 FY2026, at 2026-06-30$6.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure
Total liabilities$mnot reportednot reportednot reportednot reported5.4Total liabilities, period not labelled, at 2024-12-31$5.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-23, accession 0001193125-26-119770.Report this figure6.3Total liabilities, Q1 FY2025, at 2025-03-31$6.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure10.6Total liabilities, Q2 FY2025, at 2025-06-30$10.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0000950170-25-108116.Report this figure10.9Total liabilities, Q3 FY2025, at 2025-09-30$10.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure10.5Total liabilities, FY2025, at 2025-12-31$10.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure11.6Total liabilities, Q1 FY2026, at 2026-03-31$11.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure6.7Total liabilities, Q2 FY2026, at 2026-06-30$6.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure
Shareholders' equity$m(34.8)Shareholders' equity, period not labelled, at 2023-12-31−$34.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-23, accession 0001193125-26-119770.Report this figure(36.9)Shareholders' equity, period not labelled, at 2024-03-31−$36.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-13, accession 0000950170-25-108116.Report this figure(42.3)Shareholders' equity, period not labelled, at 2024-06-30−$42.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure(46.2)Shareholders' equity, period not labelled, at 2024-09-30−$46.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure(54.6)Shareholders' equity, period not labelled, at 2024-12-31−$54.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure151Shareholders' equity, Q1 FY2025, at 2025-03-31$150.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure137Shareholders' equity, Q2 FY2025, at 2025-06-30$136.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure122Shareholders' equity, Q3 FY2025, at 2025-09-30$122.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure107Shareholders' equity, FY2025, at 2025-12-31$106.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure87.0Shareholders' equity, Q1 FY2026, at 2026-03-31$87.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure74.8Shareholders' equity, Q2 FY2026, at 2026-06-30$74.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure

Cash flow

Operating cash flow−$17.6m, Q2 FY2026
Capital expenditure$0, Q4 FY2025
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30period not labelled2024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(2.2)Operating cash flow, period not labelled, three months to 2024-03-31−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure(4.2)Operating cash flow, period not labelled, three months to 2024-06-30−$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0000950170-25-108116. Derived: 6-month figure less the 3-month figure.Report this figure(4.0)Operating cash flow, period not labelled, three months to 2024-09-30−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-280260. Derived: 9-month figure less the 6-month figure.Report this figure(7.7)Operating cash flow, period not labelled, three months to 2024-12-31−$7.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-119770. Derived: 12-month figure less the 9-month figure.Report this figure(11.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$11.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure(9.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344987. Derived: 6-month figure less the 3-month figure.Report this figure(16.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$16.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-280260. Derived: 9-month figure less the 6-month figure.Report this figure(16.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-119770. Derived: 12-month figure less the 9-month figure.Report this figure(18.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$18.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure(17.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$17.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344987. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, period not labelled, three months to 2024-03-31$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure0.1Capital expenditure, period not labelled, three months to 2024-06-30$93.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0000950170-25-108116. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, period not labelled, three months to 2024-09-30$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-280260. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, period not labelled, three months to 2024-12-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001193125-26-119770. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$91.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-344987. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-280260. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001193125-26-119770. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)21.85m, Q2 FY2026
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares4.0Diluted shares (weighted), period not labelled, three months to 2024-03-313,967,333 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0000950170-25-071560.Report this figure4.0Diluted shares (weighted), period not labelled, three months to 2024-06-303,967,984 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0000950170-25-108116.Report this figure4.0Diluted shares (weighted), period not labelled, three months to 2024-09-303,986,997 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure13.2Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3113,194,718 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure21.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3021,690,275 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure21.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3021,713,858 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-280260.Report this figure21.8Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3121,815,995 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210675.Report this figure21.8Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3021,846,251 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure

Shares outstanding: 21.88mShares outstanding, period not labelled, at 2026-07-3121,884,846 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344987.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.